Ilika plc Appoint Keith Jackson as Chairman and form Technology Advisory Board

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology company, announced today the appointment of Keith Jackson as Chairman from the 1st January 2019, when Mike Inglis will step down from the Board.

Keith Jackson has been a Non-Executive Director of Ilika since 2014 and is also currently Chief Technology Officer at Meggitt plc, where he is responsible for technology direction and strategy. Keith has had a wide-ranging and successful career in companies varying from start-ups to multinationals. He founded and as CEO grew automotive control systems company Pi Technology. Following the successful sale of the company to Ford, he joined Rolls Royce plc and became Chief Technology Officer in the electrical power and control systems group. Keith is a Fellow of the Society of Automotive Engineers and is a graduate from University College London.

Mike Inglis was appointed a Non-Executive Director of Ilika in July 2015 and Chairman in September 2015. He has chosen the completion of a three-year period as Chairman to step down for capacity reasons following increased committee activities on his other boards. Mike will remain involved with Ilika and become the founding member of Ilika’s Technology Advisory Board, a team of industry experts to advise on the commercialisation of Ilika’s technology with specialist sector knowledge.

Graeme Purdy, Ilika plc CEO, stated:

“We are very grateful to Mike for the direction he has given the Ilika board over the past three years. He has assisted greatly in setting up the commercial framework we have established for bringing our Stereaxâ technology to market. I am delighted that Mike has agreed to be the founding member of Ilika’s Technology Advisory Board, which will be used to contribute to Ilika’s strategic direction in the coming years.”

Mike Inglis, Chairman, added:

“I have been impressed with the commercial and technical progress achieved by Ilika during my period as Chairman and I am pleased to hand over to Keith, who provides strategic continuity and brings a wealth of commercial experience, international technology and manufacturing experience to guide Ilika in its next phase.”

Keith Jackson, Chairman elect, added:

“I am delighted to accept the opportunity to guide Ilika’s board as we take the Company into its next phase of commercial exploitation.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search